NEWS
Paul Hastings Advises Trulieve on Historic NYSE Listing and Corporate Restructuring
June 10, 2026
Paul Hastings LLP advised Trulieve Cannabis Corp. (NYSE: TRLV), a leading medical cannabis company, in connection with its historic NYSE uplisting and related corporate restructuring, representing the first U.S. cannabis company to list on a major U.S. exchange after the U.S. Department of Justice issued a final rule moving state-sanctioned medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. Following medical marijuana rescheduling, Trulieve completed a corporate restructuring and investment by a third party resulting in the deconsolidation of operations in markets serving both medical and adult use customers in advance of the NYSE listing.
The Paul Hastings team was led by partners Sam Waxman and Yariv Katz and included partners Andrew Davis and Benjamin Stein, counsel Keith Pisani and Doug Brown, and associates Katie Warshauer, Greg Drozdzal and Hank Wu.
More information can be found here.
About Paul Hastings
With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers and corporations.